Cellular Senescence and Age-Associated Mechanisms

Cellular senescence is a stress-responsive state of permanent cell-cycle arrest that contributes both to tissue repair and to the progression of age-related dysfunction. Although senescent cells no longer divide, they remain metabolically active and adopt a complex secretory programme known as the senescence-associated secretory phenotype (SASP). The SASP encompasses proinflammatory cytokines, chemokines and matrix-remodelling enzymes that can reinforce growth arrest, recruit immune effectors and alter the microenvironment. With advancing age, senescent cells accumulate in multiple tissues owing to impaired immune clearance and enhanced survival pathways. Their persistence promotes chronic inflammation, extracellular matrix remodelling and stem cell dysfunction, thereby driving pathologies ranging from fibrosis to metabolic dysregulation. Immune-senescence further diminishes the capacity of the ageing immune system to recognise and eliminate aberrant or damaged cells, establishing a vicious cycle of inflammation and cellular damage. Epigenetic alterations, including DNA methylation drift, both mark and modulate biological ageing, leading to the concept of an epigenetic clock that correlates tissue methylation patterns with chronological and functional age. Together, these interconnected processes underpin the onset of chronic age-related diseases and represent targets for therapeutic intervention, such as senolytic agents that selectively ablate senescent cells or modulators of inflammatory signalling that restore tissue homeostasis.

Research from Nature Portfolio

Recent studies have shown that sublethal mitochondrial apoptotic stress, termed minority mitochondrial outer membrane permeabilisation, drives the release of mitochondrial DNA into the cytosol, activating the cGAS–STING pathway and intensifying the SASP. Pharmacological inhibition of this process in aged mice reduced systemic inflammation and improved markers of healthspan. Foundational work has also demonstrated that senescent cells upregulate anti-apoptotic proteins such as BCL-W and BCL-XL; dual inhibition of these factors selectively induces apoptosis in senescent populations and enhances stem cell function in vivo. Parallel investigations in models of age-dependent hepatic steatosis revealed that clearance of hepatocyte senescence through genetic ablation or senolytic treatment diminishes lipid accumulation and restores mitochondrial fatty-acid oxidation, suggesting cell-targeted removal as a viable approach to treat metabolic liver disease.

Cellular Senescence and Age-Associated Mechanisms publication trend

The graph below shows the total number of articles in cellular senescence and age-associated mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Cellular senescence: A state of irreversible growth arrest in response to stress, with active metabolic and secretory functions.

Senescence-associated secretory phenotype (SASP): A complex mixture of proinflammatory and tissue-modifying factors released by senescent cells.

Senolytics: Therapeutic agents that selectively induce death of senescent cells by targeting their survival pathways.

cGAS–STING pathway: A cytosolic DNA sensing mechanism that activates inflammatory responses upon detection of DNA fragments.

Immunosenescence: Age-related decline in immune function characterised by altered lymphocyte subsets and impaired pathogen clearance.

Epigenetic clock: A biomarker based on DNA methylation patterns that correlates with chronological and biological ageing.

References

1. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor. PLOS Biology (2008).
2. DNA methylation age of human tissues and cell types. Genome Biology (2013).
3. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature (2023).
4. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nature Communications (2016).
5. Cellular senescence drives age-dependent hepatic steatosis. Nature Communications (2017).
6. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell (2015).
7. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduction and Targeted Therapy (2023).
8. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?. Frontiers in Immunology (2018).
9. Extremely Differentiated T Cell Subsets Contribute to Tissue Deterioration During Aging. Annual Review of Immunology (2023).